NIPRO RENAL SOLUTIONS SPAIN S.R.
⚠️ High Risk
FEI: 3012687521 • Mollerussa, Lleida • SPAIN
FEI Number
3012687521
Location
Mollerussa, Lleida
Country
SPAINAddress
Avinguda Negrals 1, , Mollerussa, Lleida, Spain
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
DEVICEGMPS
The article is subject to refusal of admission pursuant to Section 801(a)(1) in that the methods used in, or the facilities or controls used for, the manufacture, packing, storage, or installation of the device do not conform to the requirements of Section 520(f)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) or a condition prescribed by an order under section 520(f)(2) of the FD&C Act.
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 3/6/2025 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 12/3/2024 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 8/28/2024 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 8/6/2024 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 7/8/2024 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 2780DEVICEGMPS | Division of Southeast Imports (DSEI) |
| 5/10/2023 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 2780DEVICEGMPS | Division of Southeast Imports (DSEI) |
| 5/8/2023 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | Division of Southeast Imports (DSEI) | |
| 3/28/2023 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 2/13/2023 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 2780DEVICEGMPS | Division of Southeast Imports (DSEI) |
| 2/13/2023 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 2780DEVICEGMPS | Division of Southeast Imports (DSEI) |
| 1/17/2023 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 1/17/2023 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 12/15/2022 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 6/14/2022 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 237NO PMA | Division of Southeast Imports (DSEI) |
| 1/11/2022 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 12/29/2021 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 8/12/2021 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | Division of Southeast Imports (DSEI) | |
| 3/25/2021 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | Division of Southeast Imports (DSEI) | |
| 3/2/2021 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | Division of Southeast Imports (DSEI) | |
| 11/9/2020 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 7/24/2020 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 5/16/2020 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 4/13/2020 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 10/14/2016 | 78KPODIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is NIPRO RENAL SOLUTIONS SPAIN S.R.'s FDA import refusal history?
NIPRO RENAL SOLUTIONS SPAIN S.R. (FEI: 3012687521) has 24 FDA import refusal record(s) in our database, spanning from 10/14/2016 to 3/6/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. NIPRO RENAL SOLUTIONS SPAIN S.R.'s FEI number is 3012687521.
What types of violations has NIPRO RENAL SOLUTIONS SPAIN S.R. received?
NIPRO RENAL SOLUTIONS SPAIN S.R. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about NIPRO RENAL SOLUTIONS SPAIN S.R. come from?
All FDA import refusal data for NIPRO RENAL SOLUTIONS SPAIN S.R. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.